Serums represent 44% of product type sales and fine line treatments account for 40% within the treatment type segment in 2026. The anti wrinkle products market is estimated at USD 11,645.3 million in 2026, is projected to reach USD 24,671 million by 2036 and is forecast to post a 7.8% CAGR between 2026 and 2036.